RENAL DISEASE
Clinical trials for RENAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RENAL DISEASE trials appear
Sign up with your email to follow new studies for RENAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a heart specialist at your GP visit save more lives?
Disease control OngoingThis study tests whether having extra appointments with a heart specialist at a local GP practice helps people at high risk get better treatment for heart, kidney, metabolic, and lung conditions. About 138 adults from a previous study (FIND-AF) will either receive these specialis…
Matched conditions: RENAL DISEASE
Phase: NA • Sponsor: University of Leeds • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Even controlled blood pressure can't stop these deaths – new study investigates why.
Knowledge-focused OngoingThis study reviews over 2,500 medical records to understand why some people with treated and controlled high blood pressure still die from heart attacks, strokes, kidney failure, or sudden death. Researchers are looking for overlooked factors beyond blood pressure numbers. The go…
Matched conditions: RENAL DISEASE
Sponsor: DejthidaNathaphong • Aim: Knowledge-focused
Last updated May 26, 2026 05:56 UTC
-
New digital platform aims to cut errors when patients are transferred between hospitals
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new digital platform that helps hospitals share patient information more reliably when a patient is transferred from one hospital to another. About 1,000 adults being moved to Brigham and Women's Hospital from three other hospitals will take part. The goal is t…
Matched conditions: RENAL DISEASE
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:42 UTC
-
Massive diabetes drug showdown: which one protects your heart and kidneys best?
Knowledge-focused OngoingThis study looks at health records from over 780,000 people with type 2 diabetes to compare four common second-line drugs: SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas. The goal is to see which drug is safest and most effective at preventing hear…
Matched conditions: RENAL DISEASE
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC